0.9704
price up icon4.23%   0.0394
after-market Handel nachbörslich: .99 0.0196 +2.02%
loading
Schlusskurs vom Vortag:
$0.931
Offen:
$0.95
24-Stunden-Volumen:
214.75K
Relative Volume:
0.53
Marktkapitalisierung:
$20.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.56M
KGV:
-0.1866
EPS:
-5.2
Netto-Cashflow:
$-19.35M
1W Leistung:
-5.79%
1M Leistung:
-9.31%
6M Leistung:
-55.49%
1J Leistung:
-76.02%
1-Tages-Spanne:
Value
$0.94
$1.03
1-Wochen-Bereich:
Value
$0.88
$1.07
52-Wochen-Spanne:
Value
$0.62
$7.50

Biovie Inc Stock (BIVI) Company Profile

Name
Firmenname
Biovie Inc
Name
Telefon
775-888-3162
Name
Adresse
680 W NYE LANE, CARSON CITY
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
BIVI's Discussions on Twitter

Vergleichen Sie BIVI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BIVI
Biovie Inc
0.9704 20.43M 0 -25.56M -19.35M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Biovie Inc Stock (BIVI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-07-22 Eingeleitet Cantor Fitzgerald Overweight
2021-01-15 Eingeleitet B. Riley Securities Buy

Biovie Inc Aktie (BIVI) Neueste Nachrichten

pulisher
Jun 16, 2025

New to The Street’s Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Oklahoman

Jun 16, 2025
pulisher
Jun 16, 2025

New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lubbock Avalanche-Journal

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Acquires Shares of 122,619 BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Invests $28,000 in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in BioVie LawsuitBIVI - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 07, 2025

New to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and Commercialville - The Oklahoman

Jun 07, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Buys Shares of 16,878 BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 02, 2025

The Law Offices of Vincent Wong Remind BioVie Investors of a Lead Plaintiff Deadline of March 19, 2024 - marketscreener.com

Jun 02, 2025
pulisher
May 29, 2025

Investors' Lawsuit Against BioVie Moves to Evidence Review — Here's How to Recover Losses - TradingView

May 29, 2025
pulisher
May 28, 2025

Transcript : BioVie Inc.Special Call - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

BioVie (NASDAQ:BIVI) Trading 1.9% Higher – Time to Buy? - Defense World

May 28, 2025
pulisher
May 18, 2025

FY2025 EPS Estimates for BioVie Raised by Analyst - Defense World

May 18, 2025
pulisher
May 15, 2025

BioVie Inc. Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BI - GuruFocus

May 15, 2025
pulisher
May 15, 2025

BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BIVI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

New Long COVID Treatment Hope: BioVie Launches Phase 2 Trial for 20M+ US Patients with Brain Fog - Stock Titan

May 15, 2025
pulisher
May 15, 2025

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - The Manila Times

May 15, 2025
pulisher
May 14, 2025

BioVie (BIVI) To Host Key Opinion Leader Event Discussing Parkin - GuruFocus

May 14, 2025
pulisher
May 14, 2025

BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of - GuruFocus

May 14, 2025
pulisher
May 14, 2025

BioVie to host KOL event on Phase 2 study of bezisterim - TipRanks

May 14, 2025
pulisher
May 14, 2025

BioVie Inc. to Host Virtual KOL Event Discussing Parkinson’s Disease and Update on Phase 2 SUNRISE-PD Trial for Bezisterim - Nasdaq

May 14, 2025
pulisher
May 14, 2025

BioVie to Host Virtual KOL Event to Discuss the Phase 2 - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Biovie Inc. to Host Virtual Kol Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Critical Survey: Coya Therapeutics (NASDAQ:COYA) vs. BioVie (NASDAQ:BIVI) - Defense World

May 14, 2025
pulisher
May 12, 2025

BIOVIE Earnings Results: $BIVI Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

BIOVIE INC. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Lost Money on BioVie Inc.(BIVI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

May 12, 2025
pulisher
May 11, 2025

BioVie (BIVI) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

Investors who lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

BioVie Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 19, 2024 to Discuss Your RightsBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Investors who lost money on BioVie Inc.(BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Levi & Korsinsky Reminds BioVie Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024BIVI - ACCESS Newswire

May 10, 2025
pulisher
May 09, 2025

Shareholders that lost money on BioVie Inc.(BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

INVESTOR ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Shareholders that lost money on BioVie Inc. (BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 09, 2025
pulisher
May 08, 2025

Shareholders that lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out - ACCESS Newswire

May 08, 2025
pulisher
May 07, 2025

BioVie to Present Rationale and Design of Phase 2 - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

BioVie (BIVI) Showcases Parkinson's Trial at Global Conference | BIVI Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Market Insights: BioVie Inc (BIVI)’s Notable Gain of 1.75, Closing at 1.16 - DWinneX

May 07, 2025

Finanzdaten der Biovie Inc-Aktie (BIVI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):